Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.

Autor: Mikhail, Ghada W, Prasad, Sanjay K, Li, Wei, Rogers, Paula, Chester, Adrian H, Bayne, Stephanie, Stephens, David, Khan, Mohammed, Gibbs, J.S.R, Evans, Timothy W, Mitchell, Andrew, Yacoub, Magdi H, Gatzoulis, Michael A
Zdroj: European Heart Journal; Mar2004, Vol. 25 Issue 5, p431-436, 6p
Abstrakt: Aim The treatment of patients with pulmonary arterial hypertension remains a challenge. We set out to investigate the use of sildenafil, a selective inhibitor of phosphodiesterase type 5, in patients with this disease. [ABSTRACT FROM PUBLISHER]
Databáze: Complementary Index